Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma MASTER TRIAL

Protocol No
UAB-1735-MASTER
Principal Investigator
Saurabh Chhabra
Phase
II
Summary
In this study we want to find out more about two new drugs, carfilzomib and daratumumab, in people with multiple myeloma. We want to find out whether the new drugs carflizomib and daratumumab reduce the symptoms of multiple myeloma, and whether they cause any problems (side effects).
Description
Monoclonal Antibody-Based Sequential Therapy for Deep Remission in Multiple Myeloma (MASTER)
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Share This: